Topiramate in the treatment of status epilepticus;Topiramat in der Behandlung des Status epilepticus

Nervenheilkunde

Volumn 32, Issue 4, 2013, Pages 225-229

  Rosche J ^a   Pohley, I ^a   Kampf, C ^a   Benecke, R ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Outcome criteria; Status epilepticus; Topiramate

Indexed keywords

TOPIRAMATE;

ARTICLE; DRUG EFFICACY; DRUG TREATMENT FAILURE; EPILEPTIC STATE; HUMAN; PRACTICE GUIDELINE;

EID: 84877107373     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1628504     Document Type: Article

References (40)

1. Akyildiz BN, Kumandas S. Treatment of pediatric refractory status epilepticus with topiramate. Childs Nerv Syst 2011; 27: 1425-1430.
2. Albers JM, Möddel G, Dittrich R et al. Intravenous lacosamide - an effective add-on treatment of refractory status epilepticus. Seizure 2011; 20: 428-430.
3. Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: report of three cases. Epilepsy & Behabvior 2003; 4: 757-760.
4. Blumkin L et al. Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol 2005; 20: 239-241.
5. Bragatti JA et al. Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency. Arq Neuropsiquiatr 2011; 69: 555-556.
6. Brandt C et al. Topiramate overdose: A case report of a patient with extremely high topiramate serum concentrations and nonconvulsive status epilepticus. Epilepsia 2010; 51: 1090-1093.
7. Brophy GM et al. Neurocrit Care 2012; 17: 3-23.
8. Chen JWY, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand 2007; 115 (Suppl. 186): 7-15.
9. Chen Y, Barry T, Giasson J. Rapid weight loss and decrease in hemoglobin A1c after treatment with topiramate in a patient with status epilepticus. Endocr Pract 2011; 17: 658-659.
10. Cilio MR, Bianchi R, Balestri M et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res 2009; 86: 66-71.
11. Falip M et al. Use of levetiracetam in hospitalized patients. Epilepsia 2006; 47: 2186-2188.
12. Gallentine WB, Hunnicutt AS, Husain AM. Levetiracetam in children with refractory status epilepticus. Epilepsy & Behavior 2009; 14: 215-218.
13. Goodwin H, Hinson HE, Shermock KM et al. The use of lacosamide in refractory status epilepticus. Neurocrit Care 2011; 14: 348-353.
14. Grabek-Gawlowicz M, Gawlowicz J. Possible topiramate- induced epileptic seizures. Case report. Epileptologia 2010, 18 : 99-102.
15. Hottinger A, Sutter R, Marsch St, Rüegg St. Topiramate as an adjunctive treatment in patients with refractory status epilepticus. An observational cohort study. CNS Drugs 2012; 26: 761-772.
16. Jaques L, Rossetti AO. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis. Epilepsy & Behavior 2012; 24: 70-73.
17. Kahriman M et al. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003; 44: 1353-1356.
18. Kälviäinen R. Status epilepticus treatment guidelines. Epilepsia 48; 2007 (Suppl. 8): 99-102.
19. Mameniskiene R, Bast T, Bentes C et al. Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia 2011; 52: 1168-1176.
20. Meierkord M, Boon P, Engelsen B et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17: 348-355.
21. Parkerson KA et al. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy & Behavior 2011; 20: 48-51.
22. Pittermann P, Gabriel S, Röschke J. Nonkonvulsiver Status epilepticus als Ursache eines Delirs. Psychiatr Prax 2012; 39: 189-192.
23. Rantsch K, Pohley I, Benecke R, Rösche J. Erfahrungen mit Lacosamid in der Behandlung des Status epilepticus. Akt Neurol 2012; 39: 425-428.
24. Reuber M, Evans J, Bamford JM. Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 2002; 9: 111-112.
25. Rösche J et al. Erfahrungen mit Levetiracetam in der Behandlung des Status epilepticus. Fortschr Neurol Psychiatr 2012, E-pub ahead of print.
26. Rösche J, Rantsch K, Benecke R. Pregabalin und Gabapentin als mögliche Alternativen in der Behandlung des Status epilepticus. Psychopharmakotherapie 2012; 19: 209-213.
27. Rosenow F et al. Status epilepticus im Erwachsenenalter. In: Diener HC et al. (Hrsg.). Leitlinien für Diagnostik und Therapie in der Neurologie. 5. Aufl. Stuttgart: Thieme 2012; 48-57.
28. Scott Perry M, Holt PJ, Sladky JT. Topiramate loading for refractory status epilepticus in children. Epilepsia 2006; 47: 1070-1071.
29. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An Overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000; 41 (Suppl. 1): 3-9.
30. Shiloh-Malawsky Y, Fan Z, Greenwood R et al. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure 2011; 20: 586-588.
31. Shorvon S What is nonconvulsive status epilepticus, and what are its subtypes? Epilepsia 2007; 48 (Suppl. 8): 35-38.
32. Shorvon S. Guidelines for status epilepticus: Are we there yet? Neurocrit Care 2012; 17: 1-2.
33. Soler B, Godoy J, Mellado P. Tratamiento del estado epiléptico refractario con topiramato oral. Rev Méd Chil 2009; 137: 936-939.
34. Stojanova V, Rossetti AO. Oral topiramate as an add-on treatment for refractory status epilepticus. Acta Neurol Scand 2012; 125: e7-e11.
35. Synowiec AS et al. The efficacy of topiramate in adult refractory status epilepticus: Experience of a tertiary care center. Epilepsy Research 2012; 98: 232-237.
36. Towne AR et al. The use of topiramate in refractory status epilepticus. Neurology 2003; 60; 332-334.
37. Veldkamp AI, Swart EL. Unanticipated recovery from status epilepticus after administration of levetiracetam. Br J Clin Pharmacol 2006; 62: 734-735.
38. Velizarova R, Genton P. Unilateral continuous subsclinical paroxysmal activity: an unusual finding in a patient with recurrent absence status. Epileptic Disord 2010; 12: 316-320.
39. Xiong h, Hua Y, Liu XY. Topiramate loading for treatment of a case with status epilepticus. Zhonghua Er Ke Za Zhi 2008; 46: 793-4.
40. Zelano J, Kumlien E. Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: A systematic review. Seizure 2012; 21: 233-236.